Table 6

Peak serum values of mediators in various clinical complications in acute pancreatitis (median (interquartile range))

IL-1β (pg/ml)IL-1RA (U/ml)sIL-2R (pg/ml)IL-6 (ng/ml)IL-8 (pg/ml)IL-10 (U/ml)
No sepsis (n= 40)2.93 (0.5–5.7)2751 (1717–6391) 727.3 (448–1077)427 (223–1059114 (54–706) 6.7 (3.1–12.9)
Sepsis (n= 11)4.93 (4.1–8.25)3825 (3306–6585)1528.5 (792–2224)867 (524–1507)158 (121–390)29.97 (16.42–43.5)
p ValueNSNS0.04NSNS0.02
No pulmonary dysfunction (n=33)2.8 (0.5–4.2)2751.5 (1639–4176) 581.4 (428–776) 295 (219–429) 88.2 (41–1086) 4.78 (3.1–9.8)
Pulmonary failure (n=18)7.0 (5.1–17)5495.5 (3265–8260)2224 (960–3205)1760 (989–2071)157 (95–337)31.4 (17.6–61.4)
p Value0.004NS0.0010.0005NS0.0006
No renal dysfunction (n=37)3.47 (2–5.1)3703 (2451–5453) 700 (504–971) 392 (232–693) 86.2 (65–164) 8.8 (4.4–16.8)
Renal failure (n=14)7.1 (5.9–10.4)8869 (3929–14508)3259 (2620–4261)1670 (1505–1780)155 (152–158)67.5 (40.2–97.4)
p Value0.030.030.0010.003NS0.008
  • IL, interleukin; IL-1RA, interleukin 1β receptor antagonist; sIL-2R, soluble interleukin 2 receptor.